Cetera Advisor Networks LLC Insmed Inc Transaction History

Cetera Advisor Networks LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$20.88 - $28.21 $7,621 - $10,296	-365 Reduced 3.51%	10,040 $216,000
Q2 2022 Aug 11, 2022	SELL	$17.07 - $25.71 $17,070 - $25,710	-1,000 Reduced 8.77%	10,405 $206,000
Q1 2022 May 12, 2022	BUY	$20.42 - $28.13 $30,630 - $42,195	1,500 Added 15.14%	11,405 $268,000
Q4 2021 Feb 14, 2022	BUY	$25.89 - $33.45 $25,890 - $33,450	1,000 Added 11.23%	9,905 $270,000
Q3 2021 Nov 16, 2021	BUY	$22.46 - $29.47 $200,006 - $262,430	8,905 New	8,905 $245,000
Q3 2020 Nov 13, 2020	SELL	$26.0 - $34.5 $14,040 - $18,630	-540 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$14.11 - $29.42 $7,619 - $15,886	540 New	540 $15,000

467

182M

2.27M

3.33M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.48B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisor Networks LLC with notifications on news.